The Accreditation for Cardiovascular Excellence (ACE) is proud to announce that Emory University Hospital and Emory University Hospital Midtown, Atlanta, GA, are the latest facilities recognized with provisional accreditation by ACE. Both academic hospitals successfully completed the ACE accreditation review and succeeded in demonstrating quality in cardiovascular care.

Elixir Medical Corporation, a developer of product platforms that combine state-of-the-art medical devices with advanced pharmaceuticals, announced that it has received CE (Conformité Européenne) Mark approval for its DESolve® 100 Novolimus Eluting Bioresorbable Coronary Scaffold System.

The FDA approved the antiplatelet drug vorapaxar to reduce the risk of an MI, stroke or cardiovascular death in patients with a prior MI or peripheral artery disease.

The FDA rebuffed The Medicines Company in its quest for approval of the antiplatelet agent cangrelor.

Orlando Regional Medical Center is the first hospital in Florida to utilize the Corindus CorPath System.

SCAI will launch a leadership boot camp for cath lab directors and managers at its scientific session May 28-31 in Las Vegas.

Some experts suggest FFR has a role in CABG because of its potential to spare patients a complicated surgery as well as cut costs.

An assessment of hospitals that perform primary PCI found a four-fold difference between facilities that frequently and rarely exclude patients based on non-system delays in reports on door-to-balloon (D2B) times. The variation affected compliance to the D2B metric.